ARCHIVES

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 22 No. 17 | April 26, 1996

Download PDF Visit The Full Archive

Related Articles

In Brief: Baltimore Names ACS Research Professor; Currie, Sachdeva Lead Education Association

December 9, 1994

RTOG: Hormone Therapy Increases Survival When Combined With Radiation Therapy

July 29, 2011

In Brief: San Antonia Cancer Institute Designated Comprehensive; Yeast DNA Described

May 3, 1996

Cervical Cancer Vaccine More Active In Teen Girls

February 24, 2006

NCI Requests $5.69 Billion To Seize Opportunities In FY03.

January 11, 2002

40 Years Later: Doctor and Patient Reflect on the Cure

October 24, 2014